Cargando…
SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity
BACKGROUND: The coronavirus disease 2019 (COVID-19) pandemic placed unprecedented pressure on various healthcare systems, including departments that use immunotherapies such as chimeric antigen receptor (CAR) T-cell therapy and immunosuppression therapy in organ transplantation units. The true impac...
Autores principales: | Wei, Jia, Zhao, Jianping, Han, Meifang, Meng, Fankai, Zhou, Jianfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7431770/ https://www.ncbi.nlm.nih.gov/pubmed/32727811 http://dx.doi.org/10.1136/jitc-2020-000862 |
Ejemplares similares
-
The Humoral Immune Response To SARS-CoV-2 Infection And/or Immunization in Immunocompromised Versus Immunocompetent Individuals
por: Illes, Peter, et al.
Publicado: (2022) -
Differential cellular and humoral immune responses in immunocompromised individuals following multiple SARS-CoV-2 vaccinations
por: Meredith, Rhys T., et al.
Publicado: (2023) -
Evaluation of Humoral and Cellular Responses in SARS-CoV-2 mRNA Vaccinated Immunocompromised Patients
por: Oyaert, Matthijs, et al.
Publicado: (2022) -
The Promotion of Humoral Immune Responses in Humans via SOCS1-Mediated Th2-Bias Following SARS-CoV-2 Vaccination
por: Liu, Xiaoyu, et al.
Publicado: (2023) -
SARS-CoV-2 Evolution and Immune Escape in Immunocompromised Patients
por: Scherer, Erin M., et al.
Publicado: (2022)